These drugs, initially approved for managing type 2 diabetes, have seen significant interest due to their observed benefits on weight loss. Semaglutide, a product, is one version of a GLP-1 receptor agonist, which https://lewysymte264805.aboutyoublog.com/53783574/understanding-this-medication-these-drugs-glp-1-receptor-agonists-a-explanation